Segment and Geographic Area Information | Segment and Geographic Area Information: Our three reportable segments include: (1) Lithium; (2) Bromine; and (3) Catalysts. During 2021, we changed the name of the Bromine Specialties segment to Bromine. This change simplifies the name of the reportable segment, and does not impact the operations of the business or disclosure of the related assets. Each segment has a dedicated team of sales, research and development, process engineering, manufacturing and sourcing, and business strategy personnel and has full accountability for improving execution through greater asset and market focus, agility and responsiveness. This business structure aligns with the markets and customers we serve through each of the segments. This structure also facilitates the continued standardization of business processes across the organization, and is consistent with the manner in which information is presently used internally by the Company’s chief operating decision maker to evaluate performance and make resource allocation decisions. Summarized financial information concerning our reportable segments is shown in the following tables. The “All Other” category includes only the fine chemistry services business that did not fit into any of our core businesses. On June 1, 2021, the Company completed the sale of the FCS business to Grace. See Note 3, “Divestitures,” for further details. The Corporate category is not considered to be a segment and includes corporate-related items not allocated to the operating segments. Pension and OPEB service cost (which represents the benefits earned by active employees during the period) and amortization of prior service cost or benefit are allocated to the reportable segments, All Other, and Corporate, whereas the remaining components of pension and OPEB benefits cost or credit (“Non-operating pension and OPEB items”) are included in Corporate. Segment data includes intersegment transfers of raw materials at cost and allocations for certain corporate costs. The Company’s chief operating decision maker uses adjusted EBITDA (as defined below) to assess the ongoing performance of the Company’s business segments and to allocate resources. The Company defines adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted on a consistent basis for certain non-recurring or unusual items in a balanced manner and on a segment basis. These non-recurring or unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, non-operating pension and OPEB items and other significant non-recurring items. In addition, management uses adjusted EBITDA for business planning purposes and as a significant component in the calculation of performance-based compensation for management and other employees. The Company has reported adjusted EBITDA because management believes it provides transparency to investors and enables period-to-period comparability of financial performance. Adjusted EBITDA is a financial measure that is not required by, or presented in accordance with, U.S. GAAP. Adjusted EBITDA should not be considered as an alternative to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP, or any other financial measure reported in accordance with U.S. GAAP. Year Ended December 31, 2021 2020 2019 (In thousands) Net sales: Lithium $ 1,363,284 $ 1,144,778 $ 1,358,170 Bromine 1,128,343 964,962 1,004,216 Catalysts 761,235 797,914 1,061,817 All Other 75,095 221,255 165,224 Total net sales $ 3,327,957 $ 3,128,909 $ 3,589,427 Adjusted EBITDA: Lithium $ 479,538 $ 393,093 $ 524,934 Bromine 360,682 323,605 328,457 Catalysts 106,941 130,134 270,624 All Other 29,858 84,821 49,628 Corporate (106,045) (112,915) (136,862) Total adjusted EBITDA $ 870,974 $ 818,738 $ 1,036,781 See below for a reconciliation of adjusted EBITDA, the non-GAAP financial measure, from Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with U.S. GAAP (in thousands): Lithium Bromine Catalysts Reportable Segments Total All Other Corporate Consolidated Total 2021 Net income (loss) attributable to Albemarle Corporation $ 192,244 $ 309,501 $ 55,353 $ 557,098 $ 27,988 $ (461,414) $ 123,672 Depreciation and amortization 138,772 51,181 51,588 241,541 1,870 10,589 254,000 Restructuring and other (a) — — — — — 3,027 3,027 Gain on sale of business/interest in properties, net (b) 132,400 — — 132,400 — (428,371) (295,971) Acquisition and integration related costs (c) — — — — — 12,670 12,670 Interest and financing expenses (d) — — — — — 61,476 61,476 Income tax expense — — — — — 29,446 29,446 Non-operating pension and OPEB items — — — — — (78,814) (78,814) Legacy Rockwood legal matter (d) — — — — — 657,412 657,412 Albemarle Foundation contribution (e) — — — — — 20,000 20,000 Indemnification adjustments (f) — — — — — 39,381 39,381 Other (g) 16,122 — — 16,122 — 28,553 44,675 Adjusted EBITDA $ 479,538 $ 360,682 $ 106,941 $ 947,161 $ 29,858 $ (106,045) $ 870,974 2020 Net income (loss) attributable to Albemarle Corporation $ 277,711 $ 274,495 $ 80,149 $ 632,355 $ 76,323 $ (332,914) $ 375,764 Depreciation and amortization 112,854 50,310 49,985 213,149 8,498 10,337 231,984 Restructuring and other (a) — — — — — 19,597 19,597 Acquisition and integration related costs (c) — — — — — 17,263 17,263 Interest and financing expenses — — — — — 73,116 73,116 Income tax expense — — — — — 54,425 54,425 Non-operating pension and OPEB items — — — — — 40,668 40,668 Other (h) 2,528 (1,200) — 1,328 — 4,593 5,921 Adjusted EBITDA $ 393,093 $ 323,605 $ 130,134 $ 846,832 $ 84,821 $ (112,915) $ 818,738 2019 Net income (loss) attributable to Albemarle Corporation $ 341,767 $ 279,945 $ 219,686 $ 841,398 $ 41,188 $ (349,358) $ 533,228 Depreciation and amortization 99,424 47,611 50,144 197,179 8,440 7,865 213,484 Restructuring and other (a) — — — — — 5,877 5,877 Gain on sale of property (i) — — — — — (14,411) (14,411) Acquisition and integration related costs (c) — — — — — 20,684 20,684 Interest and financing expenses (j) — — — — — 57,695 57,695 Income tax expense — — — — — 88,161 88,161 Non-operating pension and OPEB items — — — — — 26,970 26,970 Stamp duty (c) 64,766 — — 64,766 — — 64,766 Windfield tax settlement (k) 17,292 — — 17,292 — — 17,292 Other (l) 1,685 901 794 3,380 — 19,655 23,035 Adjusted EBITDA $ 524,934 $ 328,457 $ 270,624 $ 1,124,015 $ 49,628 $ (136,862) $ 1,036,781 (a) In 2021, we recorded facility closure related to offices in Germany, and severance expenses in Germany and Belgium, in SG&A. During the year ended December 31, 2020, we recorded severance expenses as part of business reorganization plans, impacting each of our businesses and Corporate, primarily in the U.S., Belgium, Germany and with our Jordanian joint venture partner. We recorded expenses of $0.7 million in Cost of goods sold, $19.2 million in SG&A and a $0.3 million gain in Net income attributable to noncontrolling interests for the portion of severance expense allocated to our Jordanian joint venture partner. In addition, we recorded severance payments as part of a business reorganization plans in Selling, general and administrative expenses for the year ended December 31, 2019. The balance of unpaid restructuring costs and severance is recorded in Accrued expenses and is expected to primarily be paid through 2022. (b) Includes a $428.4 million gain related to the FCS divestiture recorded during the year ended December 31, 2021. See Note 3, “Divestitures,” for additional information on this gain. In addition, includes a $132.4 million expense related to anticipated cost overruns for MRL’s 40% interest in lithium hydroxide conversion assets being built in Kemerton. See Note 2, “Acquisitions,” for additional information. (c) See Note 2, “Acquisitions,” for additional information. (d) Loss recorded in Other expenses, net for the year ended December 31, 2021 related to the settlement of an arbitration ruling for a legacy Rockwood legal matter. See Note 17, “Commitments and Contingencies,” for further details. (e) Included in SG&A is a charitable contribution, using a portion of the proceeds received from the FCS divestiture, to the Albemarle Foundation, a non-profit organization that sponsors grants, health and social projects, educational initiatives, disaster relief, matching gift programs, scholarships and other charitable initiatives in locations where our employees live and the Company operates. This contribution is in addition to the normal annual contribution made to the Albemarle Foundation by the Company, and is significant in size and nature in that it is intended to provide more long-term benefits in these communities. (f) Included in Other expenses, net to revise an indemnification estimate for an ongoing tax-related matter of a previously disposed business in Germany. A corresponding discrete tax benefit of $27.9 million was recorded in Income tax expense during the same period, netting to an expected cash obligation of approximately $11.5 million. (g) Included amounts for the year ended December 31, 2021 recorded in: • Cost of goods sold - $10.5 million of expense related to a legal matter as part of a prior acquisition in our Lithium business. • SG&A - $11.5 million of legal fees related to a legacy Rockwood legal matter noted above, $9.8 million of expenses primarily related to non-routine labor and compensation related costs that are outside normal compensation arrangements, a $4.0 million loss resulting from the sale of property, plant and equipment and $3.8 million of charges for environmental reserves at a sites not part of our operations. • Other expenses, net - $4.8 million of net expenses primarily related to asset retirement obligation charges to update of an estimate at a site formerly owned by Albemarle. (h) Included amounts for the year ended December 31, 2020 recorded in: • Cost of goods sold - $1.3 million of expense related to a legal matter as part of a prior acquisition in our Lithium business. • SG&A - $3.1 million of shortfall contributions for our multiemployer plan financial improvement plan and $3.8 million of a net expense primarily relating to the increase of environmental reserves at non-operating businesses we have previously divested. • Other expenses, net - $7.2 million gain related to the sale of our ownership percentage in the SOCC joint venture, $3.6 million of a net gain primarily relating to the sale of intangible assets in our Bromine business and property in Germany not used as part of our operations and a $2.5 million net gain resulting from the settlement of legal matters related to a business sold or a site in the process of being sold, partially offset by $9.6 million of losses resulting from the adjustment of indemnifications related to previously disposed businesses and $1.2 million of expenses related to other costs outside of our regular operations. (i) Gain of $3.3 million recorded in Selling, general and administrative expenses related to the release of liabilities as part of the sale of a property and $11.1 million gain recorded in Other expenses, net related to the sale of land in Pasadena, Texas not used as part of our operations. (j) Included in Interest and financing expenses is a loss on early extinguishment of debt of $4.8 million. See Note 14, “Long-Term Debt,” for additional information. (k) Represents our 49% share of a tax settlement between our Windfield joint venture and an Australian taxing authority, recorded in Equity in net income of unconsolidated investments (net of tax). This is offset in Income tax expense by a discrete tax benefit related to seeking treaty relief from the competent authority to prevent double taxation. (l) Included amounts for the year ended December 31, 2019 recorded in: • Cost of goods sold - $0.7 million related to non-routine labor and compensation related costs in Chile that are outside normal compensation arrangements. • Selling, general and administrative expenses - $1.8 million of shortfall contributions for our multiemployer plan financial improvement plan, $0.9 million of a write-off of uncollectible accounts receivable from a terminated distributor in the Bromine segment, $1.0 million related to the settlement of terminated agreements, primarily in the Catalysts segment, and $0.8 million related to the settlement of an ongoing audit in the Lithium segment. • Other expenses, net - $3.1 million of unrecoverable vendor costs outside the operations of the business related to the construction of the future Kemerton production facility, $9.8 million of a net loss primarily resulting from the adjustment of indemnifications and other liabilities related to previously disposed businesses or purchase accounting, $3.6 million of asset retirement obligation charges related to the update of an estimate at a site formerly owned by Albemarle, and $1.2 million of non-operating pension costs from our 50% interest in JBC. December 31, 2021 2020 2019 (In thousands) Identifiable assets: Lithium (a) $ 7,676,259 $ 7,134,229 $ 6,570,791 Bromine 939,808 867,648 799,456 Catalysts 1,149,592 1,066,089 1,163,590 All Other — 136,659 146,211 Corporate 1,208,459 1,246,321 1,180,815 Total identifiable assets $ 10,974,118 $ 10,450,946 $ 9,860,863 (a) Increase in Lithium identifiable assets each year primarily due to capital expenditures for growth and capacity increases. Year Ended December 31, 2021 2020 2019 (In thousands) Depreciation and amortization: Lithium $ 138,772 $ 112,854 $ 99,424 Bromine 51,181 50,310 47,611 Catalysts 51,588 49,985 50,144 All Other 1,870 8,498 8,440 Corporate 10,589 10,337 7,865 Total depreciation and amortization $ 254,000 $ 231,984 $ 213,484 Capital expenditures: Lithium $ 813,128 $ 720,563 $ 665,585 Bromine 70,711 57,486 82,208 Catalysts 49,312 44,448 57,939 All Other 2,339 6,792 7,309 Corporate 18,177 21,188 38,755 Total capital expenditures $ 953,667 $ 850,477 $ 851,796 Year Ended December 31, 2021 2020 2019 (In thousands) Net Sales (a) : United States $ 730,738 $ 743,834 $ 858,084 Foreign (b) 2,597,219 2,385,075 2,731,343 Total $ 3,327,957 $ 3,128,909 $ 3,589,427 (a) Net sales are attributed to countries based upon shipments to final destination. (b) In 2021, net sales to China, Japan and Korea represented 18%, 14% and 11%, respectively, of total net sales. In 2020, net sales to Korea, China and Japan represented 14%, 14%, and 13%, respectively, of total net sales. In 2019, net sales to Korea, China and Japan represented 17%, 13%, and 12%, respectively, of total net sales. As of December 31, 2021 2020 2019 (In thousands) Long-Lived Assets (a) : United States $ 1,040,252 $ 1,007,793 $ 1,003,496 Australia 2,736,590 2,362,377 1,981,642 Chile 1,923,821 1,814,658 1,687,090 Jordan 262,392 256,640 256,363 Netherlands 177,405 181,206 165,782 China 139,537 122,749 109,235 Germany 80,956 90,174 89,568 France 49,740 45,505 44,936 Brazil 29,474 24,393 37,165 Other foreign countries 62,667 66,273 68,499 Total $ 6,502,834 $ 5,971,768 $ 5,443,776 (a) Long-lived assets are comprised of the Company’s Property, plant and equipment and joint ventures included in Investments. |